Sort
59,101 grants matching “hypertension”
Multi-Component Behavioral Intervention for Complex Patients with CVD Risk
$636,428Richard W Grant · Kaiser Foundation Research Institute · R01 · FY2017 · HL
Urotensin II and renal insufficiency in growth-restricted infants.
$636,404Adebowale Adebiyi · University Of Tennessee Health Sci Ctr · R01 · FY2022 · DK
Heterogeneity of Satellite Cell Populations Play a Role in Improvements in PAD after Exercise Therapy
$636,387Laura Marie Hansen · Emory University · R01 · FY2024 · HL
Mechanisms of Depression in CVD
$636,326James Douglas Bremner · Emory University · R01 · FY2012 · HL
A ROLE FOR EYA3 IN VASCULAR REMODELING AND PULMONARY ARTERIAL HYPERTENSION
$636,205Rashmi S. Hegde · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · HL
A ROLE FOR EYA3 IN VASCULAR REMODELING AND PULMONARY ARTERIAL HYPERTENSION
$636,205Rashmi S. Hegde · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · HL
Control Of G Protein Signaling: Role Of The RGSs
$636,203John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
The impact of microvascular (dys)regulation on cerebral flow and oxygen heterogeneity
$636,136David A Boas · Boston University (Charles River Campus) · R01 · FY2019 · NS
Development and evaluation of community-based approaches and donor care intervention models for improving availability and safety of blood for the management of severe anemia in Ghana
$636,103Yvonne Dei-Adomakoh · University Of Ghana · UH3 · FY2022 · HL
Multi-Component Behavioral Intervention for Complex Patients with CVD Risk
$636,077Richard W Grant · Kaiser Foundation Research Institute · R01 · FY2014 · HL
Alive Blood Pressure Project: A church-based intervention to improve blood pressure
$636,032Elizabeth B Lynch · Rush University Medical Center · R01 · FY2025 · NR
Colorado Center of Childhood Liver Disease Research Network
$636,000Ronald J Sokol · University Of Colorado Denver · U01 · FY2023 · DK
Synergy of Hydroxyurea and Erythropoietin on Fetal Hemoglobin in SCD
$635,991Mark Thomas Gladwin · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
SK3 channel trafficking in endothelial cells
$635,969Jonathan H Jaggar · University Of Tennessee Health Sci Ctr · R01 · FY2021 · HL
SK3 channel trafficking in endothelial cells
$635,955Jonathan H Jaggar · University Of Tennessee Health Sci Ctr · R01 · FY2022 · HL
SK3 channel trafficking in endothelial cells
$635,955Jonathan H Jaggar · University Of Tennessee Health Sci Ctr · R01 · FY2023 · HL
2/2 CORD-CHD: Clamp OR Delay among neonates with Congenital Heart Disease
$635,944Madeline Murguia Rice · George Washington University · U24 · FY2025 · HL
Thromboregulatory strategies to prolong xenograft survival.
$635,913Simon C Robson · Beth Israel Deaconess Medical Center · U01 · FY2008 · AI
Pulmonary Hypertension in Genetically Modified Mice
$635,911Marlene Rabinovitch · Stanford University · R01 · FY2018 · HL
Action for Health in Diabetes Brain Magnetic Resonance Imaging Ancillary Study
$635,910Mark Andrew Espeland · Wake Forest University Health Sciences · R01 · FY2012 · DK
High-throughput Imaging-integrated Vascular Model for Understanding Thromboembolism and Therapeutics Screening
$635,893Y. Shrike Zhang · Brigham And Women'S Hospital · R01 · FY2023 · HL
Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework
$635,863Sterling M McPherson · Washington State University · R01 · FY2021 · AA
Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework
$635,863Sterling M McPherson · Washington State University · R01 · FY2023 · AA
Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework
$635,863Sterling M McPherson · Washington State University · R01 · FY2022 · AA
Clinical Center - Outcomes of Live Organ Donors
$635,807Arthur J Matas · University Of Minnesota · U01 · FY2008 · AI